STAAR Surgical Company

02/10/2026 | Press release | Distributed by Public on 02/10/2026 18:44

Initial Statement of Beneficial Ownership (Form 3)

FORM 3
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden hours per response... 0.5
(Print or Type Responses)
1. Name and Address of Reporting Person *
Wang Christopher Min Fang
2. Date of Event Requiring Statement (Month/Day/Year)
01/14/2026
3. Issuer Name and Ticker or Trading Symbol
STAAR SURGICAL CO [STAA]
(Last) (First) (Middle)
UNIT 3703, 37/F AIA TOWER, 183 ELECTRIC ROAD, NORTH POINT
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
__X__ Director _____ 10% Owner
_____ Officer (give title below) _____ Other (specify below)
5. If Amendment, Date Original Filed (Month/Day/Year)
(Street)
HONG KONG, K3 00000
6. Individual or Joint/Group Filing (Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
(City) (State) (Zip)
Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4)
2. Amount of Securities Beneficially Owned
(Instr. 4)
3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)
4. Nature of Indirect Beneficial Ownership
(Instr. 5)
Common Stock, par value $0.01 per share 3,257,130 I See footnote(1)
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. SEC 1473 (7-02)
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 4)
2. Date Exercisable and Expiration Date
(Month/Day/Year)
3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)
4. Conversion or Exercise Price of Derivative Security 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)
6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares

Reporting Owners

Reporting Owner Name / Address Relationships
Director 10% Owner Officer Other
Wang Christopher Min Fang
UNIT 3703, 37/F AIA TOWER
183 ELECTRIC ROAD, NORTH POINT
HONG KONG, K3 00000
X

Signatures

/s/ Christopher Min Fang Wang 02/10/2026
**Signature of Reporting Person Date

Explanation of Responses:

* If the form is filed by more than one reporting person, see Instruction 5(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1) Consists of (i) 2,575,061 shares of Common Stock, par value $0.01 per share ("Common Stock") beneficially owned by Yunqi Path Capital Master Fund, a Cayman Islands domiciled fund ("Yunqi Master Fund") and (ii) 682,069 shares of Common Stock beneficially owned by Yunqi China Special Investment A, a company incorporated in the Cayman Islands ("Yunqi A"). As the sole owner of Yunqi Capital Cayman Limited, a company incorporated in the Cayman Islands, the controller of Yunqi Master Fund, and as the Chief Investment Officer of Yunqi Capital Limited, the investment advisor of Yunqi Master Fund and Yunqi A, Mr. Wang may be deemed to beneficially own the 3,257,130 shares of Common Stock beneficially owned in the aggregate by Yunqi Master Fund and Yunqi A. Mr. Wang disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein.
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, See Instruction 6 for procedure. Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.
STAAR Surgical Company published this content on February 10, 2026, and is solely responsible for the information contained herein. Distributed via EDGAR on February 11, 2026 at 00:44 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]